 Fluoroquinolones
"Fluoroquinolones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of QUINOLONES with at least one fluorine atom and a piperazinyl group.
| Descriptor ID |
D024841
|
| MeSH Number(s) |
D03.633.100.810.835.322
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fluoroquinolones".
Below are MeSH descriptors whose meaning is more specific than "Fluoroquinolones".
This graph shows the total number of publications written about "Fluoroquinolones" by people in this website by year, and whether "Fluoroquinolones" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 | | 2000 | 1 | 1 | 2 | | 2001 | 1 | 1 | 2 | | 2002 | 1 | 0 | 1 | | 2004 | 1 | 1 | 2 | | 2006 | 0 | 1 | 1 | | 2007 | 1 | 1 | 2 | | 2008 | 1 | 0 | 1 | | 2009 | 3 | 0 | 3 | | 2010 | 2 | 1 | 3 | | 2011 | 1 | 1 | 2 | | 2013 | 1 | 2 | 3 | | 2015 | 1 | 1 | 2 | | 2016 | 1 | 3 | 4 | | 2017 | 1 | 0 | 1 | | 2018 | 0 | 3 | 3 | | 2019 | 0 | 1 | 1 | | 2020 | 0 | 3 | 3 | | 2021 | 0 | 3 | 3 | | 2024 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Fluoroquinolones" by people in Profiles.
-
Juhola J, Brennan E, Ferguson EA, Loeffler A, Hendricks A, Frosini SM, Chang YM, Bond R. Fungal dysbiosis following antibacterial monotherapy in canine otitis externa. J Small Anim Pract. 2025 03; 66(3):149-157.
-
Wu HJ, Bostic TD, Horiuchi K, Kugeler KJ, Mead PS, Nelson CA. Tularemia Clinical Manifestations, Antimicrobial Treatment, and Outcomes: An Analysis of US Surveillance Data, 2006-2021. Clin Infect Dis. 2024 01 31; 78(Suppl 1):S29-S37.
-
Engers DW, Tamma PD, Fiawoo S, Fong K, Jariwala R, Jenkins TC, Kendall RE, Lee JH, McCreary EK, Patel PK, Shihadeh KC, Slish J, Van Schooneveld TC, Malani AN. Transition to Oral Antibiotic Therapy for Hospitalized Adults With Gram-Negative Bloodstream Infections. JAMA Netw Open. 2024 01 02; 7(1):e2349864.
-
Prats-Uribe A, Sena AG, Lai LYH, Ahmed WU, Alghoul H, Alser O, Alshammari TM, Areia C, Carter W, Casajust P, Dawoud D, Golozar A, Jonnagaddala J, Mehta PP, Gong M, Morales DR, Nyberg F, Posada JD, Recalde M, Roel E, Shah K, Shah NH, Schilling LM, Subbian V, Vizcaya D, Zhang L, Zhang Y, Zhu H, Liu L, Cho J, Lynch KE, Matheny ME, You SC, Rijnbeek PR, Hripcsak G, Lane JC, Burn E, Reich C, Suchard MA, Duarte-Salles T, Kostka K, Ryan PB, Prieto-Alhambra D. Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study. BMJ. 2021 05 11; 373:n1038.
-
Haynes AS, MacBrayne CE, Parker SK. Impact of Antimicrobial Stewardship Bundle on Inpatient Use of Highly Bioavailable Antibacterials. Hosp Pediatr. 2021 05; 11(5):509-514.
-
Thompson ND, Stone ND, Brown CJ, Penna AR, Eure TR, Bamberg WM, Barney GR, Barter D, Clogher P, DeSilva MB, Dumyati G, Frank L, Felsen CB, Godine D, Irizarry L, Kainer MA, Li L, Lynfield R, Mahoehney JP, Maloney M, Nadle J, Ocampo VLS, Pierce R, Ray SM, Davis SS, Sievers M, Srinivasan K, Wilson LE, Zhang AY, Magill SS. Antimicrobial Use in a Cohort of US Nursing Homes, 2017. JAMA. 2021 04 06; 325(13):1286-1295.
-
Godfred-Cato S, Cooley KM, Fleck-Derderian S, Becksted HA, Russell Z, Meaney-Delman D, Mead PS, Nelson CA. Treatment of Human Plague: A Systematic Review of Published Aggregate Data on Antimicrobial Efficacy, 1939-2019. Clin Infect Dis. 2020 05 21; 70(70 Suppl 1):S11-S19.
-
Webb BJ, Subramanian A, Lopansri B, Goodman B, Jones PB, Ferraro J, Stenehjem E, Brown SM. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection. Antimicrob Agents Chemother. 2020 03 24; 64(4).
-
Tchesnokova VL, Rechkina E, Chan D, Haile HG, Larson L, Ferrier K, Schroeder DW, Solyanik T, Shibuya S, Hansen K, Ralston JD, Riddell K, Scholes D, Sokurenko EV. Pandemic Uropathogenic Fluoroquinolone-resistant Escherichia coli Have Enhanced Ability to Persist in the Gut and Cause Bacteriuria in Healthy Women. Clin Infect Dis. 2020 02 14; 70(5):937-939.
-
Bax BD, Murshudov G, Maxwell A, Germe T. DNA Topoisomerase Inhibitors: Trapping a DNA-Cleaving Machine in Motion. J Mol Biol. 2019 08 23; 431(18):3427-3449.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|